A Clinical Trial for Self-Injurious Behavior

NAActive, not recruitingINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

June 4, 2019

Primary Completion Date

September 9, 2025

Study Completion Date

December 31, 2025

Conditions
Self-Injurious Behavior
Interventions
BEHAVIORAL

Noncontingent Reinforcement (NCR)

This treatment for ASIB is based on reinforcer competition. Noncontingent Reinforcement (NCR) will consist of first conducting a competing stimulus assessment (CSA) to identify stimuli (toys, massagers, etc.) associated with reductions in ASIB and high levels of engagement. Treatment then involves NCR in which alternative sources of reinforcement are made freely available to compete with reinforcement maintaining ASIB. Providing additional sources of reinforcement is thought to decrease ASIB by producing a shift in the allocation of responding toward accessing the newly available reinforcement. Additional, more restrictive components may be added if the competing stimuli (CS) are ineffective in reducing ASIB. These additional components are applied in accordance to the least-restrictive treatment model and include response blocking, response reduction procedures, protective equipment, or mechanical restraint.

BEHAVIORAL

Combination Treatment

Combination Treatment is based on the same principles as NCR, but differs in three ways: 1) It includes three pre-treatment assessments that seek to establish competing stimuli, tasks, and self-control equipment through prompting and reinforcement; ; 2) Intensive training in each of these components is conducted to strengthen skills needed to fully access available reinforcement to compete with ASIB; and 3) Combination treatment is assessed, which includes the noncontingent delivery of competing stimuli and differential reinforcement of alternative behavior to reinforce engagement with competing tasks, and use of alternative self-control equipment. This will increase the amount and vary the sources of alternative reinforcement to more effectively reduce ASIB and self-restraint. Restrictive components may be applied as described for the NCR treatment.

Trial Locations (1)

21205

Kennedy Krieger Institute, Baltimore

All Listed Sponsors
lead

Hugo W. Moser Research Institute at Kennedy Krieger, Inc.

OTHER